Search

Bruker Corp

Suletud

SektorTervishoid

56.01 -0.02

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

54.67

Max

56.61

Põhinäitajad

By Trading Economics

Sissetulek

-67M

-51M

Müük

15M

839M

Aktsiakasum

0.49

Dividenditootlus

0.34

Kasumimarginaal

-6.07

Töötajad

11,085

EBITDA

-71M

17M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+9.04% upside

Dividendid

By Acuity

Dividenditootlus

Sektori keskmine

0.34%

2.24%

Järgmine tulemuste avaldamine

2. nov 2026

Järgmine dividendimakse kuupäev

1. jaan 2027

Järgmine aktsia dividendi kuupäev (ex-date)

7. dets 2026

Turustatistika

By TradingEconomics

Turukapital

-1.2B

8.6B

Eelmine avamishind

56.03

Eelmine sulgemishind

56.01

Bruker Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

13. okt 2026, 20:07 UTC

Bruker Corp shares fell, remaining near the lower end of their one-month range and below the 20-day moving average.

12. okt 2026, 20:01 UTC

Correlated Moves

Bruker Corp shares are declining amid a significant drop in 10X Genomics Inc, which has reversed a trend of higher daily closes.

8. okt 2026, 20:07 UTC

Bruker Corp shares fell sharply, continuing a three-session decline, after hitting a low shortly after the market opened and closing below the 20-day moving average.

7. okt 2026, 20:07 UTC

News
Correlated Moves

Bruker Corp's stock declined after Barclays raised its price target to $70.00, as market participants viewed the upgrade as insufficiently bullish.

6. okt 2026, 20:00 UTC

Correlated Moves

Bruker Corp shares fell sharply as the overall market declined, influenced by the performance of correlated asset 10X Genomics Inc, which is also lower.

2. okt 2026, 20:07 UTC

Bruker Corp is advancing, maintaining a strong position after closing higher since Thursday, despite pulling back slightly earlier in the session.

1. okt 2026, 19:51 UTC

Bruker Corp shares fell sharply, marking a departure from recent higher daily closes amid a broader market shift in momentum.

30. sept 2026, 21:01 UTC

Bruker Corp has declined in after-market trading, reversing earlier regular-session gains, though it remains above its 20-day moving average.

29. sept 2026, 23:11 UTC

Bruker Corp is showing an upward movement in after-market trading, with notable gains since Tuesday's close and remaining significantly above its 20-day moving average.

28. sept 2026, 20:01 UTC

News

Bruker Corporation's stock fell after an earlier gain, despite unveiling new workflows aimed at advancing drug discovery and disease research at a major conference.

25. sept 2026, 20:07 UTC

Bruker Corp shares are modestly higher, supported by a broadly advancing market, and are trading near the upper end of their one-month range.

24. sept 2026, 23:15 UTC

Bruker Corp shares are trading modestly higher in after-market hours, supported by positive economic data on jobless claims and new home sales.

23. sept 2026, 20:07 UTC

Bruker Corp's shares fell sharply after an early high, despite remaining above the 20-day moving average and near the upper end of its one-month range.

22. sept 2026, 23:01 UTC

Bruker Corp is advancing in after-market trading, reaching a peak return and remaining well above its 20-day moving average.

18. sept 2026, 20:06 UTC

Correlated Moves

Bruker Corp shares fell sharply, continuing a downward trend since Thursday, amid broader market weakness, despite earlier pulling back from a session high.

17. sept 2026, 20:07 UTC

News

Bruker Corp shares are higher, maintaining gains from Wednesday's close despite an earlier pullback, amid strong trading above its 20-day moving average.

16. sept 2026, 19:04 UTC

Bruker Corp is advancing, continuing its upward trend since Tuesday, despite earlier pulling back from a session high.

15. sept 2026, 20:01 UTC

Correlated Moves

Revvity Inc. is higher today, reflecting broader market trends despite concerns from the NY Empire State Manufacturing Index. Bruker Corp. is also advancing alongside Revvity.

11. sept 2026, 20:08 UTC

News

Bruker Corp shares are lower as UBS initiates coverage with a $65 price target. Citigroup cuts its target from $60 to $53.

10. sept 2026, 20:07 UTC

Bruker Corp shares are declining, continuing a five-session downward trend. The stock remains significantly below its 20-day moving average.

9. sept 2026, 22:06 UTC

Bruker Corp. shares were roughly flat in after-market hours. The stock is trading below its 20-day moving average after several lower closes.

2. sept 2026, 20:03 UTC

Bruker Corp shares are trading higher amid broader market dynamics. The ADP employment report may influence investor sentiment regarding interest rate policies.

1. sept 2026, 20:08 UTC

Correlated Moves

Bruker Corp shares are lower today, continuing a downward trend since Monday. Rising oil prices have fueled inflation concerns and affected market sentiment.

31. aug 2026, 23:46 UTC

Bruker Corp shares are higher in after-market trading, maintaining a gain above their 20-day moving average. No specific news was identified for the movement.

28. aug 2026, 20:02 UTC

Bruker Corp shares are declining amid broader market volatility and rising U.S. Treasury yields. Earlier, the stock pulled back from a session high.

27. aug 2026, 23:01 UTC

Bruker Corp shares are higher in after-market hours, continuing an upward trend that follows a significant rise above the 20-day moving average.

25. aug 2026, 19:26 UTC

Bruker Corp shares are higher today, reflecting overall market dynamics. No specific company news was identified to explain the movement.

24. aug 2026, 20:01 UTC

Correlated Moves

Bruker Corp shares are lower today amid sector weakness, influenced by a significant decline in Agilent Technologies and geopolitical concerns regarding oil supply disruptions.

21. aug 2026, 19:26 UTC

Bruker Corp shares are declining during Friday's session, despite a broader U.S. stock rebound. The asset earlier reached a session high before pulling back.

20. aug 2026, 19:46 UTC

Correlated Moves

Bruker Corp shares rose during Thursday's session, reflecting investor interest and aligning with gains from Thermo Fisher Scientific. The stock remains near its one-month high.

Võrdlus sarnastega

Hinnamuutus

Bruker Corp Prognoos

Hinnasiht

By TipRanks

9.04% tõus

12 kuu keskmine prognoos

Keskmine 61.333 USD  9.04%

Kõrge 80 USD

Madal 50 USD

Põhineb 10 Wall Streeti analüütiku instrumendi Bruker Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

10 ratings

6

Osta

3

Hoia

1

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Bruker Corp

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
help-icon Live chat